Long-term naltrexone treatment normalizes the pituitary response to gonadotropin-releasing hormone in polycystic ovarian syndrome

Lanzone A, Apa R, Fulghesu AM, Cutillo G, Caruso A, Mancuso S

Published April 1993 Fertility and Sterility, 59(4), 734-737
DOI 10.1016/s0015-0282(16)55851-8 PMID 8458488

Abstract

Objective

To investigate the influence of opioid system on the exaggerated LH response to GnRH test in the polycystic ovarian syndrome (PCOS).

Design

Pituitary stimulation (GnRH 100 micrograms) in a group of PCOS patients under basal condition and after 4 weeks of treatment with naltrexone.

Results

In the PCOS group, the naltrexone treatment determines a significant reduction of the LH response (calculated as the area under curve) to GnRH test, with a similar significant decrease of the LH:FSH.

Conclusion

Naltrexone normalizes in the PCOS group the pituitary response to GnRH test, abolishing every statistical differences with the control group.

By this author

Related research

Antonio Lanzone, Rosanna Apa, Anna Maria Fulghesu, Giuseppe Cutillo, Alessandro Caruso, Salvatore Mancuso
A Lanzone, R Apa, A Fulghesu, G Cutillo, A Caruso, S Mancuso
PMID 8458488 8458488 DOI 10.1016/s0015-0282(16)55851-8 10.1016/s0015-0282(16)55851-8 Lanzone et al. 1993, Lanzone 1993